Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis - ScienceDirect
Barbara Schiesser - Proprietor - Sunrise Landing Bed and Breakfast | LinkedIn
NEWSLETTER (May 2021)
Barbara Meier-Schiesser Publications by Year in Descending Order
Newly Defined ATP‐Binding Cassette Subfamily B Member 5 Positive Dermal Mesenchymal Stem Cells Promote Healing of Chronic Iron‐Overload Wounds via Secretion of Interleukin‐1 Receptor Antagonist - Vander Beken - 2019 - STEM
IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes - JCI
Loop | Barbara Meier-Schiesser
JCI - IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
Barbara Meier-Schiesser Dr. med. Dr. sc. nat. – USZ
Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis Barbara Meier-Schiesser, Laurence Feldmeyer, Dragana. - ppt download
Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis Barbara Meier-Schiesser, Laurence Feldmeyer, Dragana. - ppt download
Fakten & Mythen zu Arzneimittelreaktionen der Haut
Autoinflammatory syndromes - Meier‐Schiesser - 2021 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library
Barbara MEIER-SCHIESSER | MD PhD | University of Zurich, Zürich | UZH | Dermatologische Klinik und Poliklinik | Research profile
Phosphodiesterase-4 Inhibition Reduces Cutaneous Inflammation and IL-1β Expression in a Psoriasiform Mouse Model but Does Not Inhibit Inflammasome Activation - Zurich Open Repository and Archive
Contact
Secukinumab Therapy for Netherton Syndrome. - Abstract - Europe PMC
IJMS | Free Full-Text | Phosphodiesterase-4 Inhibition Reduces Cutaneous Inflammation and IL-1β Expression in a Psoriasiform Mouse Model but Does Not Inhibit Inflammasome Activation
Journal of the European Academy of Dermatology and Venereology: Early View
German fashion - Wikipedia
NEWSLETTER (May 2021)
Loop | Barbara Meier-Schiesser
Freitag, 04. November 2022 15:30 - 16:00 Key Note: Ulcus hypertonicum Martorell und Calciphylaxis
